Key Highlights
- which launched its initial public offering (IPO) on Monday, December 8, will conclude its subscription period on Wednesday. The IPO has been subscribed 43.417 times so far.
- The interest in the IPO was led by demand from Non-Institutional Investors who subscribed to the public issue over 130 times. The grey market premium for the IPO was topping the 'Business and Finance' trending charts today, indicating strong investor demand. The Ahmedabad-based pharmaceutical company develops, manufactures and markets products across multiple therapeutic segments, including women’s health, cardiology, pain management, and urology. With the three-day bidding coming to a close, here’s all you need to know about the Corona Remedies IPO, including its latest grey market premium (GMP), offer size, price band, allotment date, listing date and other key details. Corona Remedies IPO GMP TodayThe last grey market premium (GMP) for the Corona Remedies IPO stood at Rs 310 on December 10.
- At the upper end of the price band of Rs 1,062, the latest GMP indicates an estimated listing price of Rs 1,372 per share, implying a 29.19% premium. Note: GMP does not represent official data and is based on speculation.
- GMP data sourced from InvestorGain. Corona Remedies IPO Key DetailsThe Corona Remedies IPO is a book-built issue worth Rs 655.37 crore.
- The IPO is entirely an offer-for-sale (OFS) of 62 lakh shares. The IPO price band has been fixed at Rs 1,008 to Rs 1,062 per share.
